Answers are grounded in this paper and cite their sources.
OBJECTIVES: Colorectal cancer (CRC) is one of the most common malignancies worldwide. Since 2006, the Lombardy Region has implemented a population-based CRC screening programme with biennial faecal immunochemical test. This study describes twenty years of programme performance, impact on CRC burden and associated costs. STUDY DESIGN: Population-based longitudinal observational study. METHODS: We analysed 2006-2023 data, collected from the eight Health Protection Agencies in Lombardy and validated at regional and national levels. Key performance indicators were computed following national standards. Screening programme costs were derived from regional health budgets (2021-2024) and CRC incidence was estimated from hospital discharge data for 2002-2023. RESULTS: Invitation coverage remained above 90% across most biennial screening rounds, with participation rates averaging 45-50% before the SARS-CoV-2 pandemic and recovering to 42% afterward. Positivity rates ranged from 4% to 5%, with approximately 1000 cancers detected per biennium. Detection rates for advanced adenomas decreased over time, while low-risk adenomas increased. The average cost per screened participant ranged from €10 to €12. Adjusted CRC incidence declined from 68.8 per 100,000 in 2007 to 38.2 in 2023. CONCLUSIONS: The programme has maintained high invitation coverage and sustained screening activity over two decades, with a substantial reduction in observed CRC incidence over the same period. Persistent participation and equity gaps highlight opportunities for further improvement.
No takes yet. Share an insight, caveat, or question.
Zeduri et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: